ROBIN KOCHEL to Double-Blind Method
This is a "connection" page, showing publications ROBIN KOCHEL has written about Double-Blind Method.
Connection Strength
0.070
-
Rationale and study design for the first precision medicine randomized placebo-controlled trial in the 16p11.2 deletion syndrome. Expert Rev Neurother. 2026 Jun; 26(6):597-607.
Score: 0.046
-
Visual systemizing preference in children with autism: A randomized controlled trial of intranasal oxytocin. Dev Psychopathol. 2018 05; 30(2):511-521.
Score: 0.025